Context:
Plasmodium falciparum appears to have a particular propensity to involve the brain but the burden, risk factors, and full extent of neurological involvement have not been systematically described.
Objectives:
To determine the incidence and describe the clinical phenotypes and outcomes of neurological involvement in African children with acute falciparum malaria.
Design, Setting, And Patients:
A review of records of all children younger than 14 years admitted to a Kenyan district hospital with malaria from January 1992 through December 2004. Neurological involvement was defined as convulsive seizures, agitation, prostration, or impaired consciousness or coma.
Main Outcome Measures:
The incidence, pattern, and outcome of neurological involvement.
Results:
Of 58,239 children admitted, 19,560 (33.6%) had malaria as the primary clinical diagnosis. Neurological involvement was observed in 9313 children (47.6%) and manifested as seizures (6563/17,517 [37.5%]), agitation (316/11,193 [2.8%]), prostration (3223/15,643 [20.6%]), and impaired consciousness or coma (2129/16,080 [13.2%]). In children younger than 5 years, the mean annual incidence of admissions with malaria was 2694 per 100,000 persons and the incidence of malaria with neurological involvement was 1156 per 100,000 persons. However, readmissions may have led to a 10% overestimate in incidence. Children with neurological involvement were older (median, 26 [interquartile range {IQR}, 15-41] vs 21 [IQR, 10-40] months; P<.001), had a shorter duration of illness (median, 2 [IQR, 1-3] vs 3 [IQR, 2-3] days; P<.001), and a higher geometric mean parasite density (42.0 [95% confidence interval {CI}, 40.0-44.1] vs 30.4 [95% CI, 29.0-31.8] x 10(3)/microL; P<.001). Factors independently associated with neurological involvement included past history of seizures (adjusted odds ratio [AOR], 3.50; 95% CI, 2.78-4.42), fever lasting 2 days or less (AOR, 2.02; 95% CI, 1.64-2.49), delayed capillary refill time (AOR, 3.66; 95% CI, 2.40-5.56), metabolic acidosis (AOR, 1.55; 95% CI, 1.29-1.87), and hypoglycemia (AOR, 2.11; 95% CI, 1.31-3.37). Mortality was higher in patients with neurological involvement (4.4% [95% CI, 4.2%-5.1%] vs 1.3% [95% CI, 1.1%-1.5%]; P<.001). At discharge, 159 (2.2%) of 7281 patients had neurological deficits.
Conclusions:
Neurological involvement is common in children in Kenya with acute falciparum malaria, and is associated with metabolic derangements, impaired perfusion, parasitemia, and increased mortality and neurological sequelae. This study suggests that falciparum malaria exposes many African children to brain insults.
Citing Articles
Prevalence and factors associated with cerebral malaria among children aged 6 to 59 months with severe malaria in Western Uganda: a hospital-based cross-sectional study.
Mseza B, Kumbowi P, Nduwimana M, Banga D, Busha E, Egesa W
BMC Pediatr. 2024; 24(1):704.
PMID: 39506687
PMC: 11539429.
DOI: 10.1186/s12887-024-05178-z.
Perceptions and behaviors of healthcare providers towards rehabilitation support to children with severe malaria-related disability in Ethiopia: A qualitative descriptive study using the Theoretical Domains Framework.
Engeda E, Aldersey H, Davison C, Gelaye K, Fayed N
PLoS One. 2024; 19(5):e0298769.
PMID: 38696368
PMC: 11065226.
DOI: 10.1371/journal.pone.0298769.
Cerebral malaria presenting as nonconvulsive status epilepticus: a case report.
Wu X, Qin N, Yi F, Wang J, Yan X, Wang L
Malar J. 2024; 23(1):84.
PMID: 38500090
PMC: 10949684.
DOI: 10.1186/s12936-024-04908-z.
Admission Clinical and EEG Features Associated With Mortality and Long-term Neurologic and Cognitive Outcomes in Pediatric Cerebral Malaria.
Clark D, Bond C, Andrews A, Muller D, Sarkisian A, Opoka R
Neurology. 2023; 101(13):e1307-e1318.
PMID: 37541845
PMC: 10558167.
DOI: 10.1212/WNL.0000000000207657.
Perillyl alcohol modulates activation, permeability and integrity of human brain endothelial cells induced by Plasmodium falciparum.
Marin A, Juillard A, Katzin A, Carvalho L, Grau G
Mem Inst Oswaldo Cruz. 2023; 118:e230033.
PMID: 37403869
PMC: 10317308.
DOI: 10.1590/0074-02760230033.
Investigation of Plasma-Derived Lipidome Profiles in Experimental Cerebral Malaria in a Mouse Model Study.
Batarseh A, Vafaee F, Hosseini-Beheshti E, Safarchi A, Chen A, Cohen A
Int J Mol Sci. 2023; 24(1).
PMID: 36613941
PMC: 9820457.
DOI: 10.3390/ijms24010501.
Effectiveness of rectal artesunate as pre-referral treatment for severe malaria in children under 5 years of age: a multi-country observational study.
Hetzel M, Okitawutshu J, Tshefu A, Omoluabi E, Awor P, Signorell A
BMC Med. 2022; 20(1):343.
PMID: 36217159
PMC: 9550309.
DOI: 10.1186/s12916-022-02541-8.
An update on cerebral malaria for therapeutic intervention.
Panda C, Mahapatra R
Mol Biol Rep. 2022; 49(11):10579-10591.
PMID: 35670928
DOI: 10.1007/s11033-022-07625-5.
Acute Kidney Injury Interacts With Coma, Acidosis, and Impaired Perfusion to Significantly Increase Risk of Death in Children With Severe Malaria.
Namazzi R, Opoka R, Datta D, Bangirana P, Batte A, Berrens Z
Clin Infect Dis. 2022; 75(9):1511-1519.
PMID: 35349633
PMC: 9617576.
DOI: 10.1093/cid/ciac229.
Using EEG in Resource-Limited Areas: Comparing Qualitative and Quantitative Interpretation Methods in Cerebral Malaria.
Andrews A, Zelleke T, Izem R, Gai J, Harrar D, Mvula J
Pediatr Neurol. 2021; 126:96-103.
PMID: 34763248
PMC: 8724416.
DOI: 10.1016/j.pediatrneurol.2021.10.012.
Inverse association of falciparum positivity with endemic Burkitt lymphoma is robust in analyses adjusting for pre-enrollment malaria in the EMBLEM case-control study.
Peprah S, Ogwang M, Kerchan P, Reynolds S, Tenge C, Were P
Infect Agent Cancer. 2021; 16(1):40.
PMID: 34099001
PMC: 8186042.
DOI: 10.1186/s13027-021-00377-0.
Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria.
Marin A, Murillo O, Sussmann R, Ortolan L, Battagello D, de Castro Quirino T
Antimicrob Agents Chemother. 2021; 65(5).
PMID: 33649109
PMC: 8092904.
DOI: 10.1128/AAC.00004-21.
Prediction of disease severity in young children presenting with acute febrile illness in resource-limited settings: a protocol for a prospective observational study.
Chandna A, Aderie E, Ahmad R, Arguni E, Ashley E, Cope T
BMJ Open. 2021; 11(1):e045826.
PMID: 33495264
PMC: 7839891.
DOI: 10.1136/bmjopen-2020-045826.
A Case of Plasmodium falciparum Malaria Treated with Artesunate in a 55-Year-Old Woman on Return to Florida from a Visit to Ghana.
Rodriguez J, Roa A, Leonso-Bravo A, Khatiwada P, Eckardt P, Lemos-Ramirez J
Am J Case Rep. 2020; 21:e926097.
PMID: 33341821
PMC: 7760320.
DOI: 10.12659/AJCR.926097.
The Ins and Outs of Cerebral Malaria Pathogenesis: Immunopathology, Extracellular Vesicles, Immunometabolism, and Trained Immunity.
Sierro F, Grau G
Front Immunol. 2019; 10:830.
PMID: 31057552
PMC: 6478768.
DOI: 10.3389/fimmu.2019.00830.
Asymptomatic malaria parasitaemia and seizure control in children with nodding syndrome; a cross-sectional study.
Ogwang R, Anguzu R, Akun P, Ningwa A, Kayongo E, Marsh K
BMJ Open. 2018; 8(10):e023624.
PMID: 30341136
PMC: 6196862.
DOI: 10.1136/bmjopen-2018-023624.
Inhaled nitric oxide.
Yu B, Ichinose F, Bloch D, Zapol W
Br J Pharmacol. 2018; 176(2):246-255.
PMID: 30288739
PMC: 6295404.
DOI: 10.1111/bph.14512.
Use of a Dual-Antigen Rapid Diagnostic Test to Screen Children for Severe Plasmodium falciparum Malaria in a High-Transmission, Resource-Limited Setting.
Boyce R, Reyes R, Matte M, Ntaro M, Mulogo E, Siedner M
Clin Infect Dis. 2017; 65(9):1509-1515.
PMID: 29020298
PMC: 5850632.
DOI: 10.1093/cid/cix592.
Cost effectiveness of pre-referral antimalarial treatment in severe malaria among children in sub-Saharan Africa.
Rakuomi V, Okalebo F, Ndwigah S, Mbugua L
Cost Eff Resour Alloc. 2017; 15:14.
PMID: 28725165
PMC: 5512821.
DOI: 10.1186/s12962-017-0076-5.
Cognitive Outcomes and Psychiatric Symptoms of Retinopathy-Positive Cerebral Malaria: Cohort Description and Baseline Results.
Brim R, Mboma S, Semrud-Clikeman M, Kampondeni S, Magen J, Taylor T
Am J Trop Med Hyg. 2017; 97(1):225-231.
PMID: 28719298
PMC: 5508917.
DOI: 10.4269/ajtmh.17-0020.